Avanza Fonder’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.7M Buy
40,793
+3,126
+8% +$824K 0.2% 93
2026
Q2
$8.32M Buy
37,667
+7,612
+25% +$2.11M 0.18% 105
2026
Q1
$8.88M Sell
30,055
-2,715
-8% -$806K 0.25% 81
2025
Q4
$8.95M Buy
32,770
+3,526
+12% +$958K 0.23% 84
2025
Q3
$7.9M Buy
29,244
+2,688
+10% +$731K 0.2% 89
2025
Q2
$7.32M Buy
26,556
+4,052
+18% +$1.1M 0.22% 85
2025
Q1
$5.91M Sell
22,504
-4,014
-15% -$990K 0.19% 99
2024
Q4
$6.16M Buy
+26,518
New +$6.1M 0.18% 96

Other funds holding CME

Avanza Fonder's CME Position: Q3 2026 in Review

Avanza Fonder increased its CME Group (CME) stake by 8.3% in Q3 2026, buying an estimated $824K and bringing the position to 40,793 shares worth $10.7M. The position accounts for 0.2% of the portfolio, ranked #93.

Avanza Fonder first reported a position in CME in Q4 2024 and has held it in 8 quarters since. 1,099 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Avanza Fonder held 40,793 shares of CME Group worth $10.7M as of Q3 2026.
  • Avanza Fonder bought 3,126 CME Group shares in Q3 2026, an estimated $824K.
  • CME Group made up 0.2% of Avanza Fonder's portfolio in Q3 2026, its #93 holding.
  • Avanza Fonder first reported a position in CME Group in Q4 2024 and has held it in 8 quarters since.
  • 1,099 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Avanza Fonder's 13F filing for Q3 2026, filed 13 Oct 2026.